Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity

Keisuke Tamari, Kazuhiko Hayashi, Hideshi Ishii, Yoshihiro Kano, Masamitsu Konno, Koichi Kawamoto, Naohiro Nishida, Jun Koseki, Takahito Fukusumi, Shinichiro Hasegawa, Hisataka Ogawa, Atsushi Hamabe, Masaaki Miyo, Kozo Noguchi, Yuji Seo, Yuichiro Doki, Masaki Mori, Kazuhiko Ogawa

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Osteosarcoma is the most common primary bone malignancy in pediatric and adolescent populations. Recurrence and metastatic potential can be due to a subpopulation of cells with stem cell-like characteristics, such as tumor-initiating cells (TICs), which maintain the capacity to regenerate entire tumors. Targeting the TICs in osteosarcoma is a promising avenue for the development of new therapies for this devastating disease. TICs are usually quiescent with a low protein turnover, decreased metabolism, and downregulation of proteasome activity. Recently, cancer cells with low proteasome activity have been identified as TICs in several types of cancer. We stably infected two osteosarcoma cell lines, MG-63 and U2-OS, with an expression vector for a fusion protein between the green fluorescent protein, ZsGreen, and the C-terminal degron of the murine ornithine decarboxylase to monitor the 26S proteasome activity in living cells. We separated the osteosarcoma cells with low proteasome activity using fluorescenceactivated cell sorting (FACS) and verified whether these ZsGreen+ cells had TIC-like properties. The ZsGreen+ cells showed enhanced sphere formation capacity and underwent asymmetric divisions into ZsGreen+ and ZsGreen-cells, whereas ZsGreen-cells underwent only symmetric divisions into ZsGreen-cells. Moreover, the ZsGreen+ cells were more chemo- and radioresistant. Thus, the present study demonstrated that chemoradiation-resistant TICs can be visualized by this system and suggested the rationale for further study of osteosarcoma stem cells.

Original languageEnglish
Pages (from-to)2349-2354
Number of pages6
JournalInternational journal of oncology
Volume45
Issue number6
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Osteosarcoma
Proteasome Endopeptidase Complex
Stem Cells
Neoplastic Stem Cells
Neoplasms
Ornithine Decarboxylase
Protein C
Green Fluorescent Proteins
Proteins
Down-Regulation
Pediatrics
Bone and Bones
Recurrence
Cell Line

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. / Tamari, Keisuke; Hayashi, Kazuhiko; Ishii, Hideshi; Kano, Yoshihiro; Konno, Masamitsu; Kawamoto, Koichi; Nishida, Naohiro; Koseki, Jun; Fukusumi, Takahito; Hasegawa, Shinichiro; Ogawa, Hisataka; Hamabe, Atsushi; Miyo, Masaaki; Noguchi, Kozo; Seo, Yuji; Doki, Yuichiro; Mori, Masaki; Ogawa, Kazuhiko.

In: International journal of oncology, Vol. 45, No. 6, 01.01.2014, p. 2349-2354.

Research output: Contribution to journalArticle

Tamari, K, Hayashi, K, Ishii, H, Kano, Y, Konno, M, Kawamoto, K, Nishida, N, Koseki, J, Fukusumi, T, Hasegawa, S, Ogawa, H, Hamabe, A, Miyo, M, Noguchi, K, Seo, Y, Doki, Y, Mori, M & Ogawa, K 2014, 'Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity', International journal of oncology, vol. 45, no. 6, pp. 2349-2354. https://doi.org/10.3892/ijo.2014.2671
Tamari, Keisuke ; Hayashi, Kazuhiko ; Ishii, Hideshi ; Kano, Yoshihiro ; Konno, Masamitsu ; Kawamoto, Koichi ; Nishida, Naohiro ; Koseki, Jun ; Fukusumi, Takahito ; Hasegawa, Shinichiro ; Ogawa, Hisataka ; Hamabe, Atsushi ; Miyo, Masaaki ; Noguchi, Kozo ; Seo, Yuji ; Doki, Yuichiro ; Mori, Masaki ; Ogawa, Kazuhiko. / Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. In: International journal of oncology. 2014 ; Vol. 45, No. 6. pp. 2349-2354.
@article{6eeab033bb2e45058a573cdf3e10faa7,
title = "Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity",
abstract = "Osteosarcoma is the most common primary bone malignancy in pediatric and adolescent populations. Recurrence and metastatic potential can be due to a subpopulation of cells with stem cell-like characteristics, such as tumor-initiating cells (TICs), which maintain the capacity to regenerate entire tumors. Targeting the TICs in osteosarcoma is a promising avenue for the development of new therapies for this devastating disease. TICs are usually quiescent with a low protein turnover, decreased metabolism, and downregulation of proteasome activity. Recently, cancer cells with low proteasome activity have been identified as TICs in several types of cancer. We stably infected two osteosarcoma cell lines, MG-63 and U2-OS, with an expression vector for a fusion protein between the green fluorescent protein, ZsGreen, and the C-terminal degron of the murine ornithine decarboxylase to monitor the 26S proteasome activity in living cells. We separated the osteosarcoma cells with low proteasome activity using fluorescenceactivated cell sorting (FACS) and verified whether these ZsGreen+ cells had TIC-like properties. The ZsGreen+ cells showed enhanced sphere formation capacity and underwent asymmetric divisions into ZsGreen+ and ZsGreen-cells, whereas ZsGreen-cells underwent only symmetric divisions into ZsGreen-cells. Moreover, the ZsGreen+ cells were more chemo- and radioresistant. Thus, the present study demonstrated that chemoradiation-resistant TICs can be visualized by this system and suggested the rationale for further study of osteosarcoma stem cells.",
author = "Keisuke Tamari and Kazuhiko Hayashi and Hideshi Ishii and Yoshihiro Kano and Masamitsu Konno and Koichi Kawamoto and Naohiro Nishida and Jun Koseki and Takahito Fukusumi and Shinichiro Hasegawa and Hisataka Ogawa and Atsushi Hamabe and Masaaki Miyo and Kozo Noguchi and Yuji Seo and Yuichiro Doki and Masaki Mori and Kazuhiko Ogawa",
year = "2014",
month = "1",
day = "1",
doi = "10.3892/ijo.2014.2671",
language = "English",
volume = "45",
pages = "2349--2354",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity

AU - Tamari, Keisuke

AU - Hayashi, Kazuhiko

AU - Ishii, Hideshi

AU - Kano, Yoshihiro

AU - Konno, Masamitsu

AU - Kawamoto, Koichi

AU - Nishida, Naohiro

AU - Koseki, Jun

AU - Fukusumi, Takahito

AU - Hasegawa, Shinichiro

AU - Ogawa, Hisataka

AU - Hamabe, Atsushi

AU - Miyo, Masaaki

AU - Noguchi, Kozo

AU - Seo, Yuji

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Ogawa, Kazuhiko

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Osteosarcoma is the most common primary bone malignancy in pediatric and adolescent populations. Recurrence and metastatic potential can be due to a subpopulation of cells with stem cell-like characteristics, such as tumor-initiating cells (TICs), which maintain the capacity to regenerate entire tumors. Targeting the TICs in osteosarcoma is a promising avenue for the development of new therapies for this devastating disease. TICs are usually quiescent with a low protein turnover, decreased metabolism, and downregulation of proteasome activity. Recently, cancer cells with low proteasome activity have been identified as TICs in several types of cancer. We stably infected two osteosarcoma cell lines, MG-63 and U2-OS, with an expression vector for a fusion protein between the green fluorescent protein, ZsGreen, and the C-terminal degron of the murine ornithine decarboxylase to monitor the 26S proteasome activity in living cells. We separated the osteosarcoma cells with low proteasome activity using fluorescenceactivated cell sorting (FACS) and verified whether these ZsGreen+ cells had TIC-like properties. The ZsGreen+ cells showed enhanced sphere formation capacity and underwent asymmetric divisions into ZsGreen+ and ZsGreen-cells, whereas ZsGreen-cells underwent only symmetric divisions into ZsGreen-cells. Moreover, the ZsGreen+ cells were more chemo- and radioresistant. Thus, the present study demonstrated that chemoradiation-resistant TICs can be visualized by this system and suggested the rationale for further study of osteosarcoma stem cells.

AB - Osteosarcoma is the most common primary bone malignancy in pediatric and adolescent populations. Recurrence and metastatic potential can be due to a subpopulation of cells with stem cell-like characteristics, such as tumor-initiating cells (TICs), which maintain the capacity to regenerate entire tumors. Targeting the TICs in osteosarcoma is a promising avenue for the development of new therapies for this devastating disease. TICs are usually quiescent with a low protein turnover, decreased metabolism, and downregulation of proteasome activity. Recently, cancer cells with low proteasome activity have been identified as TICs in several types of cancer. We stably infected two osteosarcoma cell lines, MG-63 and U2-OS, with an expression vector for a fusion protein between the green fluorescent protein, ZsGreen, and the C-terminal degron of the murine ornithine decarboxylase to monitor the 26S proteasome activity in living cells. We separated the osteosarcoma cells with low proteasome activity using fluorescenceactivated cell sorting (FACS) and verified whether these ZsGreen+ cells had TIC-like properties. The ZsGreen+ cells showed enhanced sphere formation capacity and underwent asymmetric divisions into ZsGreen+ and ZsGreen-cells, whereas ZsGreen-cells underwent only symmetric divisions into ZsGreen-cells. Moreover, the ZsGreen+ cells were more chemo- and radioresistant. Thus, the present study demonstrated that chemoradiation-resistant TICs can be visualized by this system and suggested the rationale for further study of osteosarcoma stem cells.

UR - http://www.scopus.com/inward/record.url?scp=84907683817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907683817&partnerID=8YFLogxK

U2 - 10.3892/ijo.2014.2671

DO - 10.3892/ijo.2014.2671

M3 - Article

C2 - 25269626

AN - SCOPUS:84907683817

VL - 45

SP - 2349

EP - 2354

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -